AVH 2.37% $2.47 avita medical inc.

Ann: Pivotal Soft Tissue Trial Receives US FDA IDE Approval, page-11

  1. 208 Posts.
    lightbulb Created with Sketch. 129
    "The best part of this announcement is that surgeons will be able to apply for an exemption to use it."

    Exactly
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.